Placebo to match LY3537982, PEMBROLIZUMAB , PEMETREXED , CARBOPLATIN , CISPLATIN
J3M-MC-JZQB
Phase 3 small_molecule active
Quick answer
Placebo to match LY3537982, PEMBROLIZUMAB , PEMETREXED , CARBOPLATIN , CISPLATIN for Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cancer is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active